Korea's Celltrion Wins U.S. Approval for COVID-19 Rapid Test Kit

  • Arirang News

    October 27, 2020 08:24

    Korean pharmaceutical company Celltrion said on Monday its COVID-19 rapid test kit received authorization for emergency use from the U.S. Food and Drug Administration.

    The approval comes three months after the company's initial application, and with the U.S.' daily coronavirus infections continuing to soar.

    The kit, dubbed "Sampinute," can deliver test results within 10 minutes.

    • Copyright © Chosunilbo & Chosun.com
    Previous Next
    All Headlines Back to Top